Accession Number: | 0001179110-19-010490 |
Date: | 2019-09-17 |
Issuer: | KINIKSA PHARMACEUTICALS, LTD. (KNSA) |
Original Submission Date: |
MAHONEY STEPHEN F.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE, 2 CHURCH STREET
HAMILTON, D0 HM11
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SHARE OPTION | 8.83 | 2019-09-17 | deemed execution date | A | 82,000 (a) | 2029-09-16 | class a common shares 82,000 | $8.83 | 82,000 | direct |
ID | footnote |
---|---|
f1 | the option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. the vesting commencement date is september 17, 2019. |